CompareMarketResearchRequest a sample
Home / Healthcare / AI enhanced Mammography Screening

Healthcare · Market report

AI enhanced Mammography Screening Market Size, Share and Forecast 2026-2036

The global AI enhanced mammography screening market is worth USD 434 mn in 2026 and is forecast to reach USD 2.5 bn by 2036, growing at a 19.0% CAGR. United States is the largest country market and Cancer detection support is the largest by function segment.

USD 434 mnMarket size 2026
USD 2.5 bnForecast 2036
19.0%CAGR 2026-2036
United StatesLargest country

Request a free sample Jump to the forecast

Report price: Starts from USD 1,999

5 segmentation views25 countries2026 to 2036 yearly forecast

Market overview

The global AI enhanced mammography screening market is worth USD 434 mn in 2026 and is forecast to reach USD 2.5 bn by 2036, growing at a 19.0% CAGR. United States is the largest country market and Cancer detection support is the largest by function segment.

ScopeArtificial intelligence software and services that read screening mammograms and tomosynthesis to flag cancers, support double reading and estimate risk.
IndustryHealthcare
Value 2025USD 350 mn
Value 2026USD 434 mn
Value 2036USD 2.5 bn
CAGR 2026-203619.0%
Volume 202650.1 million exams
Volume 2036315 million exams
Average price 2026USD 8.66 per exam
Report priceStarts from USD 1,999
PublishedNovember 2026

Request a free sample of this report

AI enhanced Mammography Screening market size and forecast, 2026-2036

Exhibit 1The global AI enhanced mammography screening market is forecast to grow from USD 434 mn in 2026 to USD 2.5 bn by 2036, more than five times its 2026 sizeGlobal market value in USD: 2025 base year, 2026 estimate and forecast to 2036. CAGR 2026 to 2036: 19.0%
AI enhanced Mammography Screening market value, 2025 to 2036Market value by year. 2025: USD 350 mn; 2026: USD 434 mn; 2027: USD 516 mn; 2028: USD 615 mn; 2029: USD 731 mn; 2030: USD 870 mn; 2031: USD 1.0 bn; 2032: USD 1.2 bn; 2033: USD 1.5 bn; 2034: USD 1.7 bn; 2035: USD 2.1 bn; 2036: USD 2.5 bn. Compound annual growth rate 2026 to 2036: 19.0%.2025434 mn20261.0 bn20312.5 bn203619.0% CAGR

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

YearMarket value
2026USD 434 mn
2027USD 516 mn
2028USD 615 mn
2029USD 731 mn
2030USD 870 mn
2031USD 1.0 bn
2032USD 1.2 bn
2033USD 1.5 bn
2034USD 1.7 bn
2035USD 2.1 bn
2036USD 2.5 bn

AI enhanced Mammography Screening market segmentation

By function

Exhibit 2Cancer detection support is the largest segment by function, with 58.0% of 2026 revenueEstimated share of 2026 global revenue, by function
AI enhanced Mammography Screening market share by function, 2026Share of 2026 revenue by function. Cancer detection support: 58.0%; Triage and workflow: 24.0%; Risk prediction: 18.0%.Cancer detection support58.0%Triage and workflow24.0%Risk prediction18.0%

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Cancer detection support58.0%47.9%USD 252 mn16.8%
Triage and workflow24.0%27.7%USD 104 mn20.7%
Risk prediction18.0%24.4%USD 78 mn22.7%

By modality

Exhibit 3Digital breast tomosynthesis adds the most revenue by modality, growing from USD 217 mn in 2026 to USD 1.5 bn by 2036Estimated revenue in USD by modality, 2026 and 2036 forecast
AI enhanced Mammography Screening market by modality, 2026 and 2036Revenue by modality in 2026 and 2036. Digital breast tomosynthesis: USD 217 mn in 2026, USD 1.5 bn in 2036, change +611%; 2D digital mammography: USD 182 mn in 2026, USD 718 mn in 2036, change +294%; Contrast and other breast imaging: USD 35 mn in 2026, USD 209 mn in 2036, change +503%.20262036 forecastChangeDigital breast tomosynthesis+611%217 mn1.5 bn2D digital mammography+294%182 mn718 mnContrast and other breast imaging+503%35 mn209 mn

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Digital breast tomosynthesis50.0%62.5%USD 217 mn21.7%
2D digital mammography42.0%29.1%USD 182 mn14.7%
Contrast and other breast imaging8.0%8.5%USD 35 mn19.7%

By screening setting

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Population screening programmes44.0%44.0%USD 191 mn19.0%
Hospital breast centres30.0%29.0%USD 130 mn18.6%
Private imaging providers26.0%27.0%USD 113 mn19.4%

By deployment

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Cloud52.0%56.0%USD 226 mn19.9%
On-premise32.0%28.0%USD 139 mn17.4%
Hybrid16.0%16.0%USD 69 mn19.0%

By pricing model

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Per-exam fee40.0%38.0%USD 174 mn18.4%
Annual subscription38.0%41.0%USD 165 mn19.9%
Perpetual licence22.0%21.0%USD 95 mn18.4%

Top 25 countries for AI enhanced mammography screening by revenue

Countries are ranked by revenue earned from sales in the country, not by where the product is made. The ten largest hold 89.5% of 2026 revenue and the 25 countries below together hold 97.0%.

Exhibit 4United States is the largest country market at USD 200 mn in 2026, and the three largest countries hold 60.0% of global revenueEstimated 2026 revenue in USD and share of the global market, ten largest countries
AI enhanced Mammography Screening market, ten largest countries in 2026Ten largest countries by 2026 revenue. United States: USD 200 mn, 46.0%; United Kingdom: USD 35 mn, 8.0%; Germany: USD 26 mn, 6.0%; China: USD 26 mn, 6.0%; Netherlands: USD 20 mn, 4.5%; Sweden: USD 17 mn, 4.0%; Japan: USD 17 mn, 4.0%; France: USD 17 mn, 4.0%; Denmark: USD 15 mn, 3.5%; South Korea: USD 15 mn, 3.5%.United States200 mn 46.0%United Kingdom35 mn 8.0%Germany26 mn 6.0%China26 mn 6.0%Netherlands20 mn 4.5%Sweden17 mn 4.0%Japan17 mn 4.0%France17 mn 4.0%Denmark15 mn 3.5%South Korea15 mn 3.5%

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

#CountryValue 2026Share 2026Value 2036CAGR 2026-36
1United StatesUSD 200 mn46.0%USD 1.1 bn19.0%
2United KingdomUSD 35 mn8.0%USD 215 mn20.0%
3GermanyUSD 26 mn6.0%USD 136 mn18.0%
4ChinaUSD 26 mn6.0%USD 190 mn22.0%
5NetherlandsUSD 20 mn4.5%USD 101 mn17.9%
6SwedenUSD 17 mn4.0%USD 91 mn18.1%
7JapanUSD 17 mn4.0%USD 84 mn17.1%
8FranceUSD 17 mn4.0%USD 84 mn17.1%
9DenmarkUSD 15 mn3.5%USD 79 mn17.9%
10South KoreaUSD 15 mn3.5%USD 86 mn19.0%
11ItalyUSD 3.4 mn0.8%USD 19 mn18.4%
12SpainUSD 3.1 mn0.7%USD 17 mn18.5%
13CanadaUSD 2.9 mn0.7%USD 16 mn18.4%
14NorwayUSD 2.6 mn0.6%USD 14 mn18.4%
15AustraliaUSD 2.6 mn0.6%USD 14 mn18.4%
16BelgiumUSD 2.3 mn0.5%USD 12 mn18.3%
17SwitzerlandUSD 2.3 mn0.5%USD 12 mn18.3%
18FinlandUSD 2.0 mn0.5%USD 11 mn18.5%
19AustriaUSD 2.0 mn0.5%USD 11 mn18.5%
20PolandUSD 1.7 mn0.4%USD 10 mn19.9%
21IndiaUSD 1.7 mn0.4%USD 13 mn22.2%
22BrazilUSD 1.7 mn0.4%USD 12 mn21.2%
23IrelandUSD 1.7 mn0.4%USD 9.4 mn18.7%
24IsraelUSD 1.4 mn0.3%USD 8.7 mn19.7%
25SingaporeUSD 1.4 mn0.3%USD 8.7 mn19.7%
Rest of worldUSD 13 mn3.0%USD 78 mn19.8%
Exhibit 5United States and United Kingdom account for 55% of the USD 2.0 bn the market is forecast to add by 2036Forecast revenue added between 2026 and 2036 by country, in USD
AI enhanced Mammography Screening market, where the growth to 2036 comes fromRevenue added between 2026 and 2036. Market value 2026: USD 434 mn. United States: +USD 940 mn; United Kingdom: +USD 180 mn; China: +USD 164 mn; Germany: +USD 110 mn; Netherlands: +USD 82 mn; 20 other countries: +USD 496 mn; Rest of world: +USD 65 mn. Market value 2036: USD 2.5 bn.Market value 2026434 mnUnited States+940 mnUnited Kingdom+180 mnChina+164 mnGermany+110 mnNetherlands+82 mn20 other countries+496 mnRest of world+65 mnMarket value 20362.5 bn

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

Competitive landscape

Group 1: Global leaders

  • Hologic
  • Lunit
  • iCAD
  • RadNet
  • Siemens Healthineers
  • GE HealthCare

Group 2: Regional and specialist players

  • ScreenPoint Medical
  • Therapixel
  • Kheiron Medical
  • Whiterabbit.ai
  • MedCognetics
  • Volpara Health
  • Fujifilm

Group 3: Emerging and niche players

  • Vara
  • Densitas
  • Clairity

Research methodology

Every figure on this page comes from the research framework that we apply to all of the markets we cover. The 2025 base for the AI enhanced mammography screening market is built from the volume sold and the price that buyers pay, and is cross-checked against the size of the wider industry the market belongs to. Where a market can be sized in more than one way, the routes are compared before a figure is set.

The forecast runs year by year from the 2025 base to 2036. Growth in each year reflects demand from the industries that buy the product, adoption of new technology, pricing, regulation and replacement cycles. Volume and price are modelled together, so revenue in each year equals volume multiplied by average price. The 2026 to 2036 compound annual growth rate of 19.0% is calculated from the resulting values.

The market is divided by function, by modality, by screening setting, by deployment, by pricing model. The 25 largest countries are ranked by revenue earned from sales to buyers in each country, not by where the product is made. Segment values and country values add up to the market total in every year, and every report is checked for consistency before it is published.

Companies are placed in three groups: global leaders, regional and specialist players, and emerging and niche players. The groups describe how companies compete in the market. They are not a ranking and they are not market shares.

Our analysts also carry out primary research. Customized reports add interviews with key opinion leaders, such as senior executives, technical specialists and buyers, to test the assumptions behind the numbers for the question being asked.

Read the full research methodology

Frequently asked questions

How big is the AI enhanced mammography screening market?

The global AI enhanced mammography screening market is estimated at USD 350 mn in 2025 and USD 434 mn in 2026.

How fast will the AI enhanced mammography screening market grow?

It is forecast to reach USD 2.5 bn by 2036, a compound annual growth rate of 19.0% from 2026, an increase of USD 2.0 bn.

Which country is the largest market for AI enhanced mammography screening?

United States is the largest market by revenue at USD 200 mn in 2026, 46.0% of the global total. The three largest countries together hold 60.0%.

Which country is growing fastest?

Among the ten largest markets, China is growing fastest at 22.0% a year from 2026 to 2036.

Which AI enhanced mammography screening segment is largest?

In the by function split, Cancer detection support is the largest segment with 58.0% of 2026 revenue.

Who are the leading AI enhanced mammography screening companies?

Global leaders include Hologic, Lunit, iCAD, RadNet.

Need the full report?

Request a sample to see the structure, tables and country detail.

Request a free sample

Related markets in Healthcare

← AI based Triage Tools AI-Accelerated Nonclinical Drug Testing →

All Healthcare markets →

Request a sample